Charting the Course Podcast: Antivirals for Refractory CMV Infections - podcast episode cover

Charting the Course Podcast: Antivirals for Refractory CMV Infections

Aug 29, 202519 minEp. 464
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Learn to appropriately modify antiviral therapy in solid organ transplant recipients with treatment-refractory cytomegalovirus (CMV) infections with expert faculty, Atul Humar, MD, FRCP (C). Topics covered include:

  • Comparisons of available CMV antiviral therapies:
    • Ganciclovir, valganciclovir, foscarnet, cidofovir, maribavir
  • Considerations for renal function monitoring with ganciclovir and valganciclovir
  • A treatment algorithm for relapsed/refractory CMV
  • The latest clinical trial data and guideline recommendations

Presenter:
Atul Humar, MD, FRCP (C) 
Professor
Department of Medicine
University of Toronto
Eaton Family Chair in Transplant Infectious Diseases
Ajmera Transplant Centre
University Health Network
Toronto, Canada

Link to full program:
https://bit.ly/4lOa2kA

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

For the best experience, listen in Metacast app for iOS or Android